Read the full deal writeup
Sign up for a free Accredited account to read the editorial writeup, financials, and broker contact for this deal.


Full Editorial Writeup
This is an independent community pharmacy operating in one of New York City's boroughs, positioned on a high-foot-traffic street that drives walk-in volume and prescription pickups. At roughly $31M in annual revenue, this is a large-format independent pharmacy, not a corner mom-and-pop, which suggests a substantial prescription book, meaningful third-party reimbursement relationships, and likely a mix of front-end retail, OTC, and possibly specialty or compounding services.
Independent pharmacies in dense urban markets earn their position through location, prescriber relationships, insurance network participation, and customer loyalty in immigrant or underserved neighborhoods where personal service and language access matter. A $2.6M EBITDA on $31M revenue implies an 8.4% margin, which is healthy for retail pharmacy where gross margins are compressed by PBM reimbursement and generic deflation. The bulk of value here sits in the prescription file and the recurring nature of chronic-condition refills.
This sells at 4.41x EBITDA, which is a full-but-defensible multiple for a high-revenue independent with proven cash flow. The buyer is acquiring a durable, essential-service business with sticky customers, though the entire investment case rests on reimbursement durability and the concentration of payor mix, which is where the diligence must go deep.
- Two-Location Independent Retail Pharmacy, Southern California
- Medicare & Medicaid-Certified Home Healthcare Agency, Franklin County Ohio
- Northwest Ohio Skilled Home Health Agency, Joint Commission Accredited
- Two-Location Independent Pharmacy, Orange County & San Bernardino, CA
- DME & Medical Supply Business, 25-Year Los Angeles County Operator
- Multi-Location Therapy Practice, Denver Manager-Run Healthcare Group